The Allstate Co. (NYSE:ALL) Shares Sold by Xponance Inc.

Xponance Inc. lessened its stake in shares of The Allstate Co. (NYSE:ALL) by 6.5% in the fourth quarter, according to its most recent filing with the SEC. The fund owned 33,773 shares of the insurance provider’s stock after selling 2,357 shares during the period. Xponance Inc.’s holdings in Allstate were worth $4,728,000 at the end of the most recent reporting period.

Several other large investors have also modified their holdings of the stock. Sei Investments Co. increased its stake in Allstate by 40.2% in the 1st quarter. Sei Investments Co. now owns 187,869 shares of the insurance provider’s stock worth $26,022,000 after purchasing an additional 53,824 shares in the last quarter. Prudential PLC acquired a new stake in shares of Allstate during the first quarter valued at approximately $1,325,000. Cetera Investment Advisers raised its holdings in shares of Allstate by 13.9% during the first quarter. Cetera Investment Advisers now owns 23,536 shares of the insurance provider’s stock valued at $3,260,000 after acquiring an additional 2,874 shares during the period. Dakota Wealth Management purchased a new stake in shares of Allstate in the 1st quarter valued at approximately $270,000. Finally, Sequoia Financial Advisors LLC boosted its stake in Allstate by 36.2% in the 1st quarter. Sequoia Financial Advisors LLC now owns 3,237 shares of the insurance provider’s stock worth $448,000 after purchasing an additional 860 shares during the period. 76.47% of the stock is owned by institutional investors.

Insider Activity at Allstate

In other Allstate news, CAO John C. Pintozzi sold 4,000 shares of the company’s stock in a transaction on Tuesday, February 27th. The stock was sold at an average price of $159.47, for a total transaction of $637,880.00. Following the transaction, the chief accounting officer now owns 10,736 shares of the company’s stock, valued at approximately $1,712,069.92. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. In other Allstate news, insider John E. Dugenske sold 31,000 shares of the company’s stock in a transaction dated Tuesday, March 26th. The shares were sold at an average price of $170.20, for a total transaction of $5,276,200.00. Following the transaction, the insider now directly owns 63,731 shares in the company, valued at approximately $10,847,016.20. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, CAO John C. Pintozzi sold 4,000 shares of Allstate stock in a transaction on Tuesday, February 27th. The stock was sold at an average price of $159.47, for a total transaction of $637,880.00. Following the sale, the chief accounting officer now directly owns 10,736 shares of the company’s stock, valued at approximately $1,712,069.92. The disclosure for this sale can be found here. 1.80% of the stock is currently owned by company insiders.

Analyst Ratings Changes

ALL has been the subject of a number of research reports. Piper Sandler raised their price objective on Allstate from $172.00 to $188.00 and gave the stock an “overweight” rating in a research report on Monday, April 1st. HSBC upgraded shares of Allstate from a “hold” rating to a “buy” rating and raised their price target for the stock from $158.00 to $190.00 in a report on Thursday, March 28th. Morgan Stanley increased their target price on shares of Allstate from $187.00 to $190.00 and gave the stock an “overweight” rating in a research report on Monday, April 15th. Wells Fargo & Company boosted their price target on shares of Allstate from $145.00 to $146.00 and gave the company an “underweight” rating in a report on Thursday, April 11th. Finally, TheStreet raised shares of Allstate from a “c+” rating to a “b” rating in a research note on Wednesday, February 7th. One research analyst has rated the stock with a sell rating, three have issued a hold rating, thirteen have issued a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat, Allstate has a consensus rating of “Moderate Buy” and an average price target of $173.71.

Allstate Stock Up 2.3 %

NYSE ALL opened at $172.96 on Friday. The stock’s 50 day simple moving average is $163.84 and its 200 day simple moving average is $147.29. The Allstate Co. has a one year low of $100.57 and a one year high of $174.57. The firm has a market cap of $45.50 billion, a PE ratio of -139.48, a price-to-earnings-growth ratio of 0.41 and a beta of 0.52. The company has a debt-to-equity ratio of 0.51, a current ratio of 0.37 and a quick ratio of 0.37.

Allstate (NYSE:ALL) last announced its earnings results on Thursday, February 8th. The insurance provider reported $5.82 earnings per share for the quarter, beating analysts’ consensus estimates of $3.87 by $1.95. The company had revenue of $14.83 billion during the quarter, compared to analyst estimates of $12.69 billion. Allstate had a positive return on equity of 2.67% and a negative net margin of 0.33%. The firm’s quarterly revenue was up 8.7% compared to the same quarter last year. During the same period last year, the company posted ($1.36) earnings per share. As a group, sell-side analysts forecast that The Allstate Co. will post 13.49 earnings per share for the current fiscal year.

Allstate Increases Dividend

The business also recently declared a quarterly dividend, which was paid on Monday, April 1st. Stockholders of record on Monday, March 4th were paid a dividend of $0.92 per share. This is a boost from Allstate’s previous quarterly dividend of $0.89. This represents a $3.68 annualized dividend and a dividend yield of 2.13%. The ex-dividend date was Friday, March 1st. Allstate’s dividend payout ratio is -296.77%.

About Allstate

The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.